FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Novartis Consumer Health Excedrin Extra Strength Recall

Excedrin Extra Strength (Acetaminophen 250 mg, Aspirin (NSAID) 250 mg and Caffeine 65 m…

Novartis Consumer Health · Lincoln, NE

Risk level
Class II
Reported by FDA
Aug 14, 2013
Recall ID
D-843-2013
Check your lot numberHow we source this data

Summary

Novartis Consumer Health recalled Excedrin Extra Strength starting Jun 6, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-843-2013 on Aug 14, 2013. Reason: Defective container: products are packaged in pouches which may not have been fully sealed. Status: Terminated.

Why it was recalled

Defective container: products are packaged in pouches which may not have been fully sealed

Product description

Excedrin Extra Strength (Acetaminophen 250 mg, Aspirin (NSAID) 250 mg and Caffeine 65 mg), a) 2-ct tablets in pouches b) boxes of 50/2-ct packages, Distributed by Novartis Consumer Health, Inc., Parsippany, NJ, NDC 0067 2030 02 Foreign packaging: c) Parsel Forte and d) Cibalenaa (250 mg Acetaminophen, 250 mg Aspirin, 65 mg Caffeine), boxes of 48/4-ct pouches Foreign packaging do not have NDC numbers.

Lot numbers, UPCs & expiration codes

Lot #s a) 10120190, Exp 6/13 and 10121628, Exp 7/13; Lot #s b) 10115658, Exp 5/13; 10116807, Exp 5/13; 10121630, Exp 7/13 and 10125253, Exp 9/13 Foreign Lot #s c) 10120192, Exp 7/13; d)10120272, Exp 7/13, 10121528 Exp 7/13 and 10121958 Exp 8/13

Where it was sold

Nationwide, Puerto Rico, Brazil and Panama

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-843-2013
Classification
Class II
Status
Terminated
Recall initiated
Jun 6, 2013
FDA report date
Aug 14, 2013
Quantity
a) 4,178,000 pouches; b) 101,300 boxes and c) & d) 38,235 pouches and boxes (combined)
Recall type
Voluntary: Firm initiated
Recalling firm
Novartis Consumer Health

Original FDA data

Every field from FDA enforcement report D-843-2013, exactly as published.

Show all FDA fields
City
Lincoln
State
NE
Status
Terminated
Country
United States
Event ID
65422
Address
10401 Hwy 6
Code information
Lot #s a) 10120190, Exp 6/13 and 10121628, Exp 7/13; Lot #s b) 10115658, Exp 5/13; 10116807, Exp 5/13; 10121630, Exp 7/13 and 10125253, Exp 9/13 Foreign Lot #s c) 10120192, Exp 7/13; d)10120272, Exp 7/13, 10121528 Exp 7/13 and 10121958 Exp 8/13
Postal code
68517-9626
Report date
Aug 14, 2013
Product type
Drugs
Recall number
D-843-2013
Classification
Class II
Recalling firm
Novartis Consumer Health
Product quantity
a) 4,178,000 pouches; b) 101,300 boxes and c) & d) 38,235 pouches and boxes (combined)
Termination date
Nov 4, 2014
Reason for recall
Defective container: products are packaged in pouches which may not have been fully sealed
Voluntary / mandated
Voluntary: Firm initiated
Product description
Excedrin Extra Strength (Acetaminophen 250 mg, Aspirin (NSAID) 250 mg and Caffeine 65 mg), a) 2-ct tablets in pouches b) boxes of 50/2-ct packages, Distributed by Novartis Consumer Health, Inc., Parsippany, NJ, NDC 0067 2030 02 Foreign packaging: c) Parsel Forte and d) Cibalenaa (250 mg Acetaminophen, 250 mg Aspirin, 65 mg Caffeine), boxes of 48/4-ct pouches Foreign packaging do not have NDC numbers.
Distribution pattern
Nationwide, Puerto Rico, Brazil and Panama
Recall initiation date
Jun 6, 2013
Initial firm notification
Letter
Center classification date
Aug 6, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-843-2013, published Aug 14, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls